Cargando…

Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

BACKGROUND: The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. METHODS: We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Blondel, Guillaume, Lescure, François-Xavier, Assoumou, Lambert, Charpentier, Charlotte, Chapplain, Jean-Marc, Perpoint, Thomas, Grouteau, Gaspard, Cordel, Hugues, Pialoux, Gilles, Pacanowski, Jérome, Thy, Michael, Bauvois, Adeline, Laureillard, Didier, Hamrouni, Fadia, Algarte-Genin, Michèle, Poissy, Julien, Descamps, Diane, Costagliola, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189443/
https://www.ncbi.nlm.nih.gov/pubmed/35698029
http://dx.doi.org/10.1186/s12879-022-07508-x
Descripción
Sumario:BACKGROUND: The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. METHODS: We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patients infected by historical lineages. Participants were matched on age (± 2.5 years), sex and region of hospitalization. The primary endpoint was the proportion of hospitalized participants with severe COVID-19, defined as a WHO-scale > 5 or by the need of a non-rebreather mask, occurring up to day 29 after admission. We used a logistic regression model stratified on each matched pair and accounting for factors known to be associated with the severity of the disease. RESULTS: We included 650 pairs of patients hospitalized between Jan 1, 2021, and Feb 28, 2021, in 47 hospitals. Median age was 70 years and 61.3% of participants were male. The proportion of participants with comorbidities was high in both groups (85.0% vs 90%, p = 0.004). Infection by VOC Alpha was associated with a higher odds of severe COVID-19 (41.7% vs 38.5%—aOR = 1.33 95% CI [1.03–1.72]). CONCLUSION: Infection by the VOC Alpha was associated with a higher odds of severe COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07508-x.